Bristol-Myers Squibb denies claims in Merck Sharp & Dohme’s misuse of market power case

Competition & Consumer Protection 2021-08-06 3:06 pm | Sydney
Pharmaceutical giant Bristol-Myers Squibb will fight a case brought by Merck Sharp & Dohme alleging misuse of market power over stage IV melanoma treatments, telling the Federal Court on Friday it denied its rival’s claims.
For information on rights and reprints, contact subscriptions@lawyerly.com.au